Skip to main content

PARTNERS CAPITAL INVESTMENT GROUP, LLP

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1694870 Boston, MA

Position in ALLO

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$394,296
+$172,909 QoQ
Shares Held
161,597
0.0% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PARTNERS CAPITAL INVESTMENT GROUP, LLP holds $5,149,749 across 5 Biotechnology names. ALLO ranks #4 (7.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 ALLO
Allogene Therapeutics, Inc.
This page
161,597 $394,296

All Filings in ALLO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $394,296 161,597
2025-12-31 $221,387 161,597
2025-09-30 $200,380 161,597
2025-06-30 $182,604 161,597
2025-03-31 $372,073 254,845
2024-12-31 $198,618 93,248
2024-09-30 $713,566 254,845
2024-06-30 $1,059,788 454,845
2024-03-31 $416,818 93,248
2023-12-31 $1,460,052 454,845
2023-09-30 $1,441,858 454,845
2023-06-30 $2,260,579 454,845
2023-03-31 $460,645 93,248
2022-12-31 $586,529 93,248
2022-09-30 $1,007,078 93,248
2022-06-30 $1,063,027 93,248
2022-03-31 $849,489 93,248
2021-12-31 $1,391,260 93,248
2021-09-30 $2,396,473 93,248
2021-06-30 $2,431,907 93,248
2021-03-31 $3,733,116 105,754
2020-12-31 $3,300,533 130,766
2020-09-30 $5,166,986 137,019
2020-06-30 $6,365,792 148,664
2020-03-31 $3,246,285 166,990